Predictive oncology stock.

Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country. EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ...Quotes Summary Real-Time After-Hours Pre-Market Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is …

Hernandez-Boussard, T., Macklin, P., Greenspan, E.J. et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med 27, 2065–2066 (2021 ...For Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

Predictive Oncology : This medical AI innovator has plenty of potential. Duos Technologies ( DUOT ): Duos is a rising tech player that has just surpassed its penny stock status.

Nov 24, 2023 · Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis. Predictive Oncology has a market capitalisation of US$21m and burnt through US$13m last year, which is 64% of the company's market value. Given how large that cash burn is, relative to the market ...On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334.

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.

Against this backdrop, HLGN stock has carved out a place on watch lists this week. Predictive Oncology Inc. (POAI) There is no shortage of excitement around AI stocks. Thanks to the popularity of ChatGPT, there’s been a surge of interest in any company with exposure to the industry.

Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ...Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the game in drug … Home Read More » On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334.Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis. 4 analysts have issued 12 month price targets for Ikena Oncology's stock. Their IKNA share price targets range from $11.00 to $13.00. On average, they expect the company's share price to reach $11.67 in the next twelve months. This suggests a possible upside of 677.8% from the stock's current price.Predictive Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. POAI updated stock price target summary.Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate.

Predictive Oncology (POAI) has 2 splits in our Predictive Oncology stock split history database. The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI …In today’s data-driven world, businesses are constantly seeking ways to gain a competitive edge. One powerful tool that has emerged in recent years is predictive analytics programs.

Pfizer (PFE) Pfizer (NYSE:PFE) remains one of the more polarizing stocks in the biotech sector. And unfortunately for investors, it’s also one of the most beaten-down stocks. Since closing at an ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comPredictive Oncology Inc. (POAI) Stock Price | Stock Quote Nasdaq - MarketScreener PREDICTIVE ONCOLOGY INC. Predictive Oncology Inc. Stock price …

The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.

Aug 16, 2023 · Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock.

It has seen a strong drop off this year (as have most small-market speculative stocks in this space), bringing the market cap down to $24 million. In terms of their sales and projections, I believe this is undervalued. POAI is projected to do $1.6mil this year, which is not a huge number but having any revenue for a company in this early stage ...The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Find real-time POAI - Predictive Oncology Inc stock quotes, company profile, news and forecasts from CNN Business. Apr 20, 2023 · Predictive Oncology’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted basis when the market opens on Monday ... The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ... ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...२०२० जुन ३० ... ... Predictive Oncology Inc: * PREDICTIVE ONCOLOGY FILES PROSPECTUS RELATES TO OFFER, RESALE OF UP TO 1.7 MILLION SHARES OF COMMON STOCK BY ...Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...

On Thursday 05/25/2023 the closing price of the Predictive Oncology Inc Registered Shs share was $3.07 on NAS. Compared to the opening price on Thursday 05/25/2023 on NAS of $3.01, this is a gain ...२०२३ मार्च १३ ... $POAI - Predictive Oncology - Extremely Undervalued Growth/AI Biotech Stock? DD. I've recently been looking into various stocks in the oncology ...Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model.The company owns a biorepository of tumor samples, a lab and a good manufacturing practice ...Instagram:https://instagram. semi conductor stocktriad vs 21st mortgagebest scalping platform1 yr treasury rate The first of these is Predictive Oncology (NASDAQ: POAI). The company uses a proprietary AI platform to identify drugs that are likely to work against specific tumors. To facilitate this, the ... premarker moversstrategy trading forex Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ...Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. vfsux vanguard 3 analysts have issued 1 year price objectives for Surface Oncology's stock. Their SURF share price targets range from $3.00 to $6.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 320.6% from the stock's current price. View analysts price targets for SURF or view …12 brokers have issued 12-month price objectives for Rain Oncology's stock. Their RAIN share price targets range from $11.00 to $24.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 1,431.5% from the stock's current price.Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.